GEN Magazine Volume 28, Issue No. 3, February 1 2008 Website Content From This Issue Website Content from This IssueNewsWeb Exclusive: GEN’s Annual Wall Street RoundupFebruary 1, 2008InsightsDriving Discovery from Inside OutFebruary 1, 2008InsightsqPCR Poised for Prime TimeFebruary 1, 2008InsightsFirms Need to Focus on ProfitsFebruary 1, 2008InsightsNew Act Endangers Long-Term Patent ValidityFebruary 1, 2008InsightsGEN’s Annual Wall Street Analyst RoundupFebruary 1, 2008InsightsBioMarket Trends: Phalanx of Treatments Propels Burn MarketFebruary 1, 2008InsightsCompany Update: Protagen Zeroes In on Protein TherapeuticsFebruary 1, 2008InsightsTrubion Tackles Second-Generation mAbsFebruary 1, 2008InsightsStreamlining Gene Delivery with MicroporationFebruary 1, 2008InsightsAssay: Single-Molecule Sequencing AdvancesFebruary 1, 2008InsightsDNA Methylation Bolsters Cancer ResearchFebruary 1, 2008InsightsWinning the Contamination Control BattleFebruary 1, 2008InsightsAiming at Easier Scale-Up in Protein ProductionFebruary 1, 2008InsightsStem Cells Advance on Multiple FrontsFebruary 1, 2008InsightsCombination Therapies Fortify Oncology FightFebruary 1, 2008
